Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

15.52 -0.41 (-2.57%)

Streaming Delayed Price Updated: 1:29 PM EDT, Jun 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ethos Technologies Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

aTyr Pharma to Participate in April Investor Conferences

April 01, 2024

From aTyr Pharma, Inc.

Via GlobeNewswire

3 Penny Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 26, 2024

Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.

Via InvestorPlace

LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023 ↗

March 14, 2024

LIFE stock results show that aTyr Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Recap: aTyr Pharma Q4 Earnings ↗

March 14, 2024

Via Benzinga

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

March 14, 2024

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma's Earnings Outlook ↗

March 13, 2024

Via Benzinga

Analyst Expectations for aTyr Pharma's Future ↗

September 21, 2023

Via Benzinga

The Latest Analyst Ratings for aTyr Pharma ↗

May 23, 2023

Via Benzinga

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

aTyr Pharma: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Where aTyr Pharma Stands With Analysts ↗

March 10, 2023

Via Benzinga

aTyr Pharma's Earnings: A Preview ↗

March 08, 2023

Via Benzinga

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results

February 28, 2024

Management to host conference call and webcast on March 14th at 5:00 pm EDT / 2:00 pm PDT

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants

February 21, 2024

From aTyr Pharma, Inc.

Via GlobeNewswire

The 3 Best Penny Stocks to Buy in February 2024 ↗

February 15, 2024

With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies.

Via InvestorPlace

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

January 29, 2024

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor

January 18, 2024

Dr. Frederick to advise Company on corporate affairs and commercial strategy for efzofitimod in interstitial lung disease (ILD).

From aTyr Pharma, Inc.

Via GlobeNewswire

Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!

November 13, 2023

The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,...

Via IssueWire

Topics Religion

aTyr Pharma to Present at November Investor Conferences

November 01, 2023

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

October 31, 2023

Multiple centers in the U.S. are open for enrollment

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes

September 11, 2023

From aTyr Pharma, Inc.

Via GlobeNewswire

$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

August 02, 2023

The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...

Via Benzinga

aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst ↗

July 05, 2023

Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 ↗

July 05, 2023

Via Benzinga

7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023 ↗

June 28, 2023

Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns.

Via InvestorPlace

3 Stocks and Cryptos With the Highest Potential Returns ↗

May 07, 2023

If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market.

Via InvestorPlace

7 Hot Growth Stocks Poised to Triple in 2023 ↗

May 05, 2023

These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher.

Via InvestorPlace

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 09, 2023

We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 08, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

All News about Ethos Technologies Inc. - Class A Common Stock